Will These Patents Help Amarin Shareholders?

Amarin's (Nasdaq: AMRN  ) share price took a hit this month after the Food and Drug Administration announced that it has still not decided whether the company's flagship drug, Vascepa, qualifies for New Chemical Entity, or NCE, status. Shares of Amarin are up today, however, on news that two new patents have been approved for Vascepa.

Although patents are an essential long-term shield against generic competition, will this really move the needle for Amarin's stock in the short term? Is NCE status still the biggest catalyst that investors need to watch?

In the following video, health care analysts Max Macaluso and Brenton Flynn discuss these issues.

The biotech space can make or break investors overnight, and while Amarin might not disappear into thin air, the success of its new triglyceride-lowering drug is key to the company's future. The company has huge potential and a number of risks -- so don't invest a dollar before reading everything you need to know about Amarin. You can start now with top Fool.com analyst Max Macaluso's premium research report. Click here now to keep reading.

Max Macaluso, Ph.D. and Brenton Flynn hold no positions in the stocks mentioned above. The Motley Fool owns shares of Dendreon and Abbott Laboratories. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2070945, ~/Articles/ArticleHandler.aspx, 9/22/2014 4:37:16 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement